APA

Anasetti C., Martin P. J., Hansen J. A., Appelbaum F. R., Beatty P. G., Doney K., Harkonen S., Jackson A., Reichert T. & Stewart P. (19900813). A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. : Transplantation.

Chicago

Anasetti C, Martin P J, Hansen J A, Appelbaum F R, Beatty P G, Doney K, Harkonen S, Jackson A, Reichert T and Stewart P. 19900813. A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. : Transplantation.

Harvard

Anasetti C., Martin P. J., Hansen J. A., Appelbaum F. R., Beatty P. G., Doney K., Harkonen S., Jackson A., Reichert T. and Stewart P. (19900813). A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. : Transplantation.

MLA

Anasetti C, Martin P J, Hansen J A, Appelbaum F R, Beatty P G, Doney K, Harkonen S, Jackson A, Reichert T and Stewart P. A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. : Transplantation. 19900813.